3 reports

The increased incidence of chronic diseases such as cardiovascular diseases (CVDs), diabetes, chronic obstructive pulmonary disease (COPD), end-stage renal disease (ESRD), and urology disorders have led to the rise in number of patients globally.

  • Insulin Delivery
  • World
  • Market Size
  • Medtronic, Inc.
  • Omron Corporation

The Nanopump is less than one fourth the size of existing insulin-pump devices and can be worn as a nearly invisible patch on the skin.

  • Insulin
  • Insulin Delivery
  • Therapy
  • Germany
  • Debiotech S.A.

Closed acquisition of the AMS male urology portfolio from Endo International plc, further strengthening Boston Scientific' s leadership in urology and pelvic health.

  • Insulin Delivery
  • Medical Device
  • North America
  • United States
  • AtriCure, Inc.